Information  X 
Enter a valid email address

BP PLC (BP.)

  Print      Mail a friend       Annual reports

Thursday 15 August, 2019

BP PLC

Q2 2019 Scrip Dividend Reference Price

RNS Number : 1881J
BP PLC
15 August 2019
 

15 August 2019

 

BP p.l.c.

Second quarter interim dividend for 2019

Scrip Dividend Programme

 

On 30 July 2019, the Directors of BP p.l.c. announced that the interim dividend for the second quarter 2019 would be US$0.1025 per ordinary share (US$0.615 per ADS). This interim dividend is to be paid on 20 September 2019 to shareholders on the share register on 9 August 2019. The dividend is payable in cash in sterling to holders of ordinary shares and in US dollars to holders of ADSs. A scrip dividend alternative will be made available for this dividend allowing shareholders to elect to receive their dividend in the form of new ordinary shares and ADS holders in the form of new ADSs.

 

The 'Reference Share Price' for the issue of new ordinary shares under the scrip dividend alternative is:

 

US$6.070 for each new ordinary share.

 

For holders of ordinary shares this is equivalent to 1 new share for

approximately every 59.220 shares held prior to the ex-dividend

date of 8 August 2019.

 

The Reference Share Price is the average of the US dollar equivalent of the closing mid price quotation for a BP ordinary share on the London Stock Exchange Daily Official List for the five consecutive dealing days beginning on the ex-dividend date of 8 August 2019. The US dollar equivalent price each day is calculated from the sterling closing mid price using an exchange rate published in the London Stock Exchange Daily Official List.

 

The 'Reference ADS Price' for the issue of new ADSs under the scrip dividend alternative is:

US$36.470 for each new ADS.

 

For holders of ADSs this is equivalent to 1 new ADS for

approximately every 59.301 ADSs held prior to the ex-dividend

date of 8 August 2019.

 

The Reference ADS Price is calculated by multiplying the Reference Share Price by six (as there are six ordinary shares underlying each ADS) and adjusting for the fee payable to the Depositary under the ADS Deposit Agreement (US$0.05 per ADS). Prior to the 2012 first quarter dividend payment stamp duty reserve tax ("SDRT") of 1.5% was deducted from this calculation, but following a tax tribunal decision in 2012, HM Revenue & Customs will no longer seek to impose 1.5% SDRT on issues of UK shares and securities to non-EU clearance services and depositary receipt systems.

 

Dividends payable in cash in sterling on 20 September 2019 will be converted from US dollars at the average of the market exchange rates for the four dealing days from 4 to 9 September 2019. The sterling cash dividend will be announced to the London Stock Exchange on 10 September 2019.

 

The latest date for receipt of elections to participate in the Scrip Dividend Programme for this interim dividend is 3 September 2019. Shareholders must return their mandate form or otherwise input their CREST elections, to be received by BP's Registrar, Link, by 5.00 pm (London time) on 3 September 2019, and ADS holders must return their election form to the Depositary, JPMorgan Chase Bank N.A., by 5.00 pm (New York time) on that date. Elections received after this deadline will apply to subsequent dividends only. Unless revoked by you, your scrip dividend election will apply for all future dividends for which a scrip dividend is offered.  Evergreen elections for CREST shareholders will not be accepted and elections will revert to cash by default after the payment of each dividend.

 

Details of the second quarter 2019 dividend and timetable are available at www.bp.com/dividends and details of the Scrip Dividend Programme are available at www.bp.com/scrip.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DIVLIFFATVIELIA

a d v e r t i s e m e n t